Stephen G. Noorduyn
ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: June 25, 2026
Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled Trial.
Journal: Advances in therapy
Published: June 12, 2026
Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.
Journal: Advances in therapy
Published: March 31, 2026
Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial.
Journal: Journal of asthma and allergy
Published: February 03, 2026
Exacerbations and Healthcare Burden of COPD with Type 2 Inflammation: US Claims Analysis.
Journal: International journal of chronic obstructive pulmonary disease
Published: January 10, 2026
Is Clinical Remission, an Ambitious Treatment Goal, Achievable in Patients with Moderate-to-Severe Asthma on Inhaled Therapies: How Ambitious Should We Be?
Journal: Journal of clinical medicine
Published: December 10, 2025
Profiles and Disease Burden of Patients with COPD Initiating Triple Therapy in China.
Journal: International journal of chronic obstructive pulmonary disease
Published: November 28, 2025
Response to: Letter to the Editor Regarding "Comparative Effectiveness of FF/1 UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy".
Journal: Advances in therapy
Published: November 21, 2025
A Pragmatic RCT of FF/UMEC/VI in Patients with Uncontrolled Asthma: PERFORM Protocol.
Journal: Pulmonary therapy
Published: November 10, 2025
FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study.
Journal: Advances in therapy
Published: October 22, 2025
Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study.
Journal: Pulmonary therapy
Published: September 02, 2025
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.
Journal: Respiratory medicine
Published: August 19, 2025
Last Updated: 09/26/2026